期刊文献+

兴奋毒性在肌萎缩侧索硬化的发病机制中具有重要作用

Excitotoxicity plays an important role in the pathologic progress of amyotrophic lateral sclerosis.
下载PDF
导出
摘要 目的:分析比较肌萎缩侧索硬化病人和神经系统正常的受试者脑脊液中的谷氨酸水平,以明确由谷氨酸介导的“兴奋毒性”是否在ALS的发病机制中具有作用。方法:肌萎缩侧索硬化病人15例,神经系统正常的外科手术腰麻病人20例,采集脑脊液后用氨基酸自动分析仪进行检测。结果:肌萎缩侧索硬化病人脑脊液中谷氨酸水平与对照比较增高有极显著差异(两组分别为48.81±31.67μmol/L和15.85±6.70μmol/L)(P(0.01)。结论:由谷氨酸介导的“兴奋毒性”在肌萎缩侧索硬化的发病过程具有重要作用。 Objective: Compare the concentration of glutamate(Glu) in the cerebrospinal fluid(CSF) of patients with amyotrophic lateral sclerosis( ALS) and those with healthy nervous system to make definite the role of excitotoxicity mediated by Glu in the pathogenesis of ALS. Methods: Subjects were 15 patients with ALS and 20 neurologically normal patients who underwent lumbar anesthesia for surgery. Analyzed their CSF by amino acid measuring machine which utilized the principle of high performance liquid chromatography( HPLC). Results: The concentration of Glu was higher in patients with ALS (48. 81 ±31. 67μmol/L) than in controls (15. 85 ± 6. 70μmol/L) (P<0. 01). Conclusions: The excitotoxicity mediated by Glu plays an important role in the pathologic progress of ALS.
出处 《脑与神经疾病杂志》 2004年第2期81-83,共3页 Journal of Brain and Nervous Diseases
关键词 兴奋毒性 肌萎缩侧索硬化 谷氨酸 脑脊液 Amyotrophic lateral sclerosis, Glutamate, Excitotoxicity
  • 相关文献

参考文献12

  • 1Van den Bosch L, Van Damme P, Vleminckx V, et al. An alphamercaptoacrylic acid derivative(PD150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibition. Neuropharmacology, 2002, Apr; 42 (5) :
  • 2Kruman Ⅱ ,Pedersen WA, Springer JE, et al. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol, 1999: 160( 1 ): 28 ~29
  • 3Shaw PJ. Excitotoxicity and motor neurone disease:a review of the evidence. Journal of the Neurological Sciences, 1994; 124(suppl) :6-13
  • 4Hand CK, Rouleau GA. Familial amyotrophic lateral sclerosis.Muscle Nerve, 2002 Fed; 25(2):135-59
  • 5Morrison KE. Therapies in amyotrophic lateral sclerosis-beyond riluzole. Curr Opin Pharmacol, 2002 Jun; 2(3):302-9
  • 6Heath PR, Shaw PJ. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve, 2002, Oct, 26(4):438-58
  • 7Andrew Eisen. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle &amp; Nerve, 1995,18:741-752
  • 8Canu W, Billiard M, Baldy-Mouliner M. Fasting plasma and CSF amino acid levels in ALS. Acta Neurol Scand, 1993, 88:51-55
  • 9Plaitakis A, Constantakakis E. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in ALS. Brain Res Bull 1993,30:381-386
  • 10Rothstein JD, Van Kammen M, Levey AI, et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.Ann Neurol, 1995,38:73-84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部